Goldenwell Biotech, Inc.
GWLL· OTC
GWLLGoldenwell Biotech, Inc.
Quarterly figures for Goldenwell Biotech, Inc., with source filings when available.
28 quarters. Sep 30, 2019 to Jun 30, 2026. USD.
Goldenwell Biotech, Inc. has filed its 10-Q within 45 to 92 days of period end across its last 8 quarters. The 10-K runs 91 to 135 days.
Goldenwell Biotech, Inc. · CIK 1800373 · Engraved from SEC EDGAR
| Period | Ended | Announced | Filed | Lag | Form | Revenue | Δ yoy | EPS dil. | Source trail |
|---|---|---|---|---|---|---|---|---|---|
| FY 2026 | |||||||||
| Q2 2026 | Jun 30, 2026 | — | Aug 14, 2026 | 45 d | 10-Q | $0.00 | — | $0.00 | |
| Q1 2026 | Mar 31, 2026 | — | Jul 1, 2026 | 92 d | 10-Q | $0.00 | — | $0.00 | |
| FY 2025 | |||||||||
| Q4 2025 | Dec 31, 2025 | — | Jul 1, 2026 | 182 d | 10-K | $55.00 | — | $0.00 | |
| Q3 2025 | Sep 30, 2025 | — | Dec 8, 2025 | 69 d | 10-Q | ||||
| FY 2024 | |||||||||
| Q4 2024 | Dec 31, 2024 | — | May 15, 2025 | 135 d | 10-K | $0.00 | −100.0% | $0.00 | |
| Q3 2024 | Sep 30, 2024 | — | Nov 26, 2024 | 57 d | 10-Q | ||||
| FY 2023 | |||||||||
| Q4 2023 | Dec 31, 2023 | — | Apr 12, 2024 | 103 d | 10-K | $260.00 | — | — | |
| Q3 2023 | Sep 30, 2023 | — | Nov 13, 2023 | 44 d | 10-Q | ||||
| FY 2022 | |||||||||
| Q4 2022 | Dec 31, 2022 | — | Apr 13, 2023 | 103 d | 10-K | $0.00 | −100.0% | — | |
| Q3 2022 | Sep 30, 2022 | — | Nov 14, 2022 | 45 d | 10-Q | ||||
| FY 2021 | |||||||||
| Q4 2021 | Dec 31, 2021 | — | Apr 1, 2022 | 91 d | 10-K | $2.70K | — | — | |
| Q3 2021 | Sep 30, 2021 | — | Jan 3, 2022 | 95 d | |||||
| FY 2020 | |||||||||
| Q4 2020 | Dec 31, 2020 | — | Jul 23, 2021 | 204 d | 10-K | — | — | — | |
| Q3 2020 | Sep 30, 2020 | — | Feb 23, 2021 | 146 d | 10-Q | ||||
| FY 2019 | |||||||||
| Q4 2019derived | Dec 31, 2019 | — | — | — | — | — | — | — | |
| Q3 2019 | Sep 30, 2019 | — | — | — | — | $0.00 | — | — | |
| $0.00 |
| — |
| — |
| Q2 2025 | Jun 30, 2025 | — | Sep 12, 2025 | 74 d | 10-Q | $0.00 | −100.0% | — |
|---|
| Q1 2025 | Mar 31, 2025 | — | May 27, 2025 | 57 d | 10-Q | $0.00 | −100.0% | $0.00 |
|---|
| $0.00 |
| −100.0% |
| — |
| Q2 2024 | Jun 30, 2024 | — | Aug 22, 2024 | 53 d | 10-Q | $139.00 | −49.6% | — |
|---|
| Q1 2024 | Mar 31, 2024 | — | May 20, 2024 | 50 d | 10-Q | $158.00 | −88.9% | $0.00 |
|---|
| $382.00 |
| −99.1% |
| — |
| Q2 2023 | Jun 30, 2023 | — | Aug 17, 2023 | 48 d | 10-Q | $276.00 | −92.6% | — |
|---|
| Q1 2023 | Mar 31, 2023 | — | May 19, 2023 | 49 d | 10-Q | $1.42K | +258.2% | — |
|---|
| $43.69K |
| +259.1% |
| — |
| Q2 2022 | Jun 30, 2022 | — | Aug 15, 2022 | 46 d | 10-Q | $3.71K | +235.7% | — |
|---|
| Q1 2022 | Mar 31, 2022 | — | May 18, 2022 | 48 d | 10-Q | $397.00 | — | — |
|---|
| 10-Q |
| $12.17K |
| — |
| — |
| Q2 2021 | Jun 30, 2021 | — | Dec 2, 2021 | 155 d | 10-Q | $1.11K | — | — |
|---|
| Q1 2021 | Mar 31, 2021 | — | Aug 5, 2021 | 127 d | 10-Q | $0.00 | — | — |
|---|
| $0.00 |
| — |
| — |
| Q2 2020 | Jun 30, 2020 | — | — | — | — | — | — | — |
|---|
| Q1 2020 | Mar 31, 2020 | — | — | — | — | $0.00 | — | — |
|---|
